Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Directorate Change

14 Dec 2018 07:00

RNS Number : 4593K
Ebiquity PLC
14 December 2018
 

 

 Ebiquity plc

("Ebiquity" or "the Company")

 

Directorate Change

 

Ebiquity, a leading independent global media and marketing consultancy, is pleased to announce the appointment of Alan Newman as Chief Financial and Operating Officer. Alan will join the Company on 7th January 2019 and be appointed as an executive Director of the Board. Kevin McNair, currently Interim Chief Financial Officer, will step down from the role and the Board on 7th January 2019.

 

Alan has extensive public company experience having spent almost ten years as CFO of YouGov plc, the AIM-listed global market research and data analytics group. He is currently Chair of the Audit Committee of Future plc and Deputy Chair of the Quoted Companies Alliance. Prior to YouGov plc, Alan was a partner at EY and previously at KPMG where he provided board level advisory and consulting services specialising in the media, technology and telecoms sector. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

Michael Karg, Group CEO, Ebiquity says: 

 

"Alan is an exceptional addition to Ebiquity's executive team. He brings a vital combination of public company and media sector expertise as we continue our business transformation. I and the team look forward to working closely with him."

 

Alan Newman says:

 

"Ebiquity is well positioned to take advantage of media industry trends and I feel this is an exciting time to join the business. I look forward to being part of an inspiring team and working with Michael and the Executive team to help Ebiquity to develop and successfully exploit its market opportunities."

 

 

Further information on Alan Newman

Mr Newman (full name Alan Philip Stephen Newman), aged 61 currently holds the following directorships:

Future plc

Freud Museum London (registered charity)

The Quoted Companies Alliance

Freud Museum Publications Limited

Newlawns Limited

 

 

Mr Newman has been a Director of the following companies within the last five years:

YouGov plc

YouGov Services Limited

YGV Finance Limited

YouGovStone Limited

Portent.io Limited

CoEditor Limited

Doughty Media 2 Limited

YouGov America Inc.

YouGov Deutschland GmbH

YouGov France SASU

YouGov Malaysia Sdn, Bhd

YouGov M.E. Egypt LLC

YouGov M.E. FZ-LLC

YouGov Nordic &Baltic A/S

YouGov Research Pty Limited

YouGov Thailand Company Limited

PT YouGov Consulting Indonesia

Consilium Limited, Hong Kong

 

Anyada Limited

 

There is no further information required to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM rules.

14 December 2018

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Mark Sanford (Company Secretary)

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOATJBMTMBIBTAP
Date   Source Headline
8th Sep 20083:00 pmRNSResult of AGM
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.